SLDB Operating Cash Flow (Statement)
Solid Biosciences Inc · Operating Cash Flow (Statement)
SLDB Operating Cash Flow (Statement)
Latest reported-$186.84Mperiod ending
SLDB TTM Cash from Operations (-$43.22M → -$186.84M)
TTM operating cash flow (statement)
High-resolution chart · PNG
SLDB operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -186,844,000 | |
| -171,669,000 | |
| -156,289,000 | |
| -132,379,000 | |
| -122,615,000 | |
| -106,670,000 | |
| -100,012,000 | |
| -91,190,000 | |
| -85,379,000 | |
| -91,377,000 | |
| -94,180,000 | |
| -107,837,000 | |
| -110,369,000 | |
| -98,782,000 | |
| -97,977,000 | |
| -84,371,000 | |
| -82,366,000 | |
| -83,588,000 | |
| -77,764,000 | |
| -55,583,000 | |
| -52,723,000 | |
| -48,691,000 | |
| -56,599,000 | |
| -79,151,000 | |
| -82,828,000 | |
| -96,061,000 | |
| -92,714,000 | |
| -92,873,000 | |
| -88,922,000 | |
| -78,952,000 | |
| -70,197,000 | |
| -62,775,000 | |
| -56,924,000 | |
| -50,200,000 | |
| -43,224,000 | |
| -34,816,000 |